Branded Generics Market Forecast to 2028

Report Code : TIPRE00005554 | Region : Global | Industry : Pharmaceuticals | Published Date : 13/Jun/2022
Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)

The global branded generics market is projected to reach US$ 414.99 billion by 2028 from US$ 235.86 billion in 2022; it is expected to grow at a CAGR of 9.9% from 2022 to 2028.

Rising penetration of branded generics and increasing government initiatives for promoting branded generics drive the growth of branded generics market. Encouraging utility of branded generics by healthcare providers and professionals acts as a future trend in the branded generics market.

The Association for Accessible Medicines report states that nearly 3.9 billion generic prescriptions were dispensed in 2016. Therefore, branded generics present a viable opportunity for potential growth for big pharma players. According to the published report by HSRII, the US is the largest pharmaceutical market in the world (US$ 325 billion), accounting for one-third of the global pharmaceutical market, with generics accounting for 84% in terms of sales volume and 28% in terms of sales value. Furthermore, branded generics utilization has increased among the population due to savings provided by the healthcare system and the ability to invest in tomorrow's new medicines. For instance, nearly 3.9 billion prescriptions dispensed in the US are for generics. Moreover, on average, in 2016, the use of generic medicines saved each state US$ 4.9 billion compared to the price of relevant branded medicines. This further means that Medicaid savings averaged US$ 744 million, and state Medicaid savings averaged US$ 1.5 billion per state. Such factors accelerate the demand for branded generics, fueling the overall market growth during the forecast period.

Additionally, the rise in government initiatives for promoting branded generics further is accelerating the adoption of branded generics, ultimately stimulating the overall market growth. A Scientific Electronic Library Online (SciELO) report states that promoting branded generics constitutes a core instrument for countries' national pharmaceutical policies, ultimately reducing drug expenditure with expanding healthcare access. For example, to make quality generic medicines available at affordable prices, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in November 2008. The scheme focused on dedicated outlets known as Janaushadhi Kendras, offering generic medicines at affordable prices. Till 2021, 8,012 Janaushadhi Kendras were functional across the country. Moreover, a Food and Drug Administration (FDA) report states that as the FDA approves more branded generics, it results in a drop in cost. Generally, multiple generic drugs for the same product create marketplace competition. For example, a single generic competitor results in price reductions of up to 30%, while five competing generics are associated with a price drop of nearly 85%.

The global branded generics market is segmented based on therapeutic application, distribution channel, drug class, and formulation type. Based on therapeutic application, the branded generics market is segregated into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and others. The others segment is estimated to account for the largest market share during 2022–2028. However, the oncology segment is likely to register the highest CAGR during the forecast period. Generic drugs are also widely used in supportive care during the chemotherapy treatment for oncology. According to the Indian Council for Medical Research (ICMR), in India, the number of Indians who have cancer is projected to increase from 26.7 billion in 2022 to 29.8 billion by 2025. As per the Pharma Intelligence Center, there are currently 1,351 generic drugs available in India for the treatment of various cancers as of February 26, 2021. Most drugs are for the treatment of hematological malignancies, such as blood cancer (606) and leukemia (428). As the cost of branded drugs is higher than generic drugs, maximum people cannot afford these branded drugs and consume generic drugs. Treatment of cancer is limited by the affordability of patients in many developing countries, including India. Therefore, generic drug manufacturers are manufacturing drugs available at affordable costs, often at less than 10% of the original brand cost. It is observed that there is a three-fold higher prescription of generic brands compared to innovators, accompanied by cost savings of up to 80% per prescription. However, the regulatory environment prevailing in India is favorable to ensure satisfactory generic products. These factors are responsible for the growth of this segment, which, eventually, is expected to aid the growth of branded generics market during the forecast period. The others segment is categorized into infectious diseases, musculoskeletal diseases, respiratory diseases, and oral health. According to the Centers for Disease Control and Prevention, in 2018, ~100,000 people in the US suffered from various infectious diseases. Thus, the prevalence of infectious diseases and respiratory diseases, which are treated using generics, is mainly driving the others segment, contributing a considerable share in the branded generics market during the forecast period.

Market Opportunities of Global Branded Generics Market

The opportunity for global branded generics market is product differentiation. The pharmaceutical industry is one of the most intensively regulated sectors, and as a result of these challenges, returns on R&D investment in the pharmaceutical industry have decreased. One feasible alternative for addressing such challenges is adopting strategies such as product differentiation to reduce development costs and maximize profits. Product differentiation deals with developing innovative products based on an existing product by creating better features, performance, or efficacy. Product differentiation paves the way for strengthening product pipeline and lifecycle management. As generic drugs contain the same active pharmaceutical ingredients as the brand-name product, differentiation in the color, shape, taste, inactive ingredients, preservatives, and packaging result in high demand for branded generics globally. Therefore, differentiation in the final product is expected to offer lucrative growth opportunities for the competitive players in the branded generics market.

Additionally, prominent players in the market are focusing on offering low-cost branded generics to remain competitive in the market. This can be achieved by strategically sourcing raw materials from emerging economies and partnering with suppliers. The above factors support the overall branded generics market growth during the forecast period.

The Pan-Canadian Pharmaceutical Alliance, Canadian Generic Pharmaceutical Association, Centers for Disease Control and Prevention, US Food and Drug Administration, International Finance Corporation, and Indian Brand Equity Foundation are among the primary and secondary sources referred to while preparing the report on the global branded generics market.

The List of Companies - Branded Generics Market

1. MYLAN N.V.

2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

3. GlaxoSmithKline plc

4. Bausch Health (Valeant Pharmaceuticals)

5. Sandoz International Gmbh

6. Aspen Holdings

7. Par Pharmaceuticals

8. Lupin

9. Sanofi

10. AstraZeneca

11. Dr. Reddy's Laboratories Inc.

12. Hetero

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Branded Generics Market – By Therapeutic Application

1.3.2 Global Branded Generics Market – By Distribution Channel

1.3.3 Global Branded Generics Market – By Drug Class

1.3.4 Global Branded Generics Market – By Formulation Type

1.3.5 Global Branded Generics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Branded Generics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Branded Generics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Penetration of Branded Generics

5.1.2 Increasing Government Initiatives for Promoting Branded Generics

5.2 Market Restraints

5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3 Market Opportunities

5.3.1 Product Differentiation

5.4 Future Trends

5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals

5.5 Impact Analysis

6. Branded Generics Market– Global Analysis

6.1 Global Branded Generics Market Revenue Forecast and Analysis

6.2 Global Branded Generics Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

6.4 Global Branded Generics Market – Market Potential Analysis, By Region

6.5 Comparative Company Analysis

6.6 Growth Strategy Analysis

6.7 Performance of Key Players

6.7.1.1 Teva Pharmaceuticals Industries Ltd.

6.7.1.2 Sandoz International GmbH

6.8 Market Share Analysis of Branded Generics Market

7. Global Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1 Overview

7.2 By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5 Diabetes

7.5.1 Overview

7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6 Neurology

7.6.1 Overview

7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7 Gastrointestinal Diseases

7.7.1 Overview

7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8 Dermatology Diseases

7.8.1 Overview

7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9 Analgesics and Anti-Inflammatory

7.9.1 Overview

7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10 Others

7.10.1 Overview

7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

8. Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1 Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2 Hospital Pharmacies

8.2.1 Overview

8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3 Retail Pharmacies

8.3.1 Overview

8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4 Online Pharmacies

8.4.1 Overview

8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5 Drug Stores

8.5.1 Overview

8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9. Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1 Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2 Alkylating Agents

9.2.1 Overview

9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3 Antimetabolites

9.3.1 Overview

9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4 Hormones

9.4.1 Overview

9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5 Anti-hypertensive

9.5.1 Overview

9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6 Lipid Lowering Drugs

9.6.1 Overview

9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7 Anti-Depressants

9.7.1 Overview

9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8 Anti-psychotics

9.8.1 Overview

9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9 Anti-epileptic

9.9.1 Overview

9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10 Others

9.10.1 Overview

9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10. Global Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1 Overview

10.2 Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3 Oral

10.3.1 Overview

10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4 Parenteral

10.4.1 Overview

10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5 Topical

10.5.1 Overview

10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6 Others

10.6.1 Overview

10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

11. Branded Generics Market Revenue and Forecasts to 2028 Geographical Analysis

11.1 North America: Branded Generics Market

11.1.1 Overview

11.1.2 North America: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.3 North America: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.4 North America: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.5 North America: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.6 North America: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7 North America: Branded Generics Market, by Country, 2022 & 2028 (%)

11.1.7.1 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.1.1 Overview

11.1.7.1.2 US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.1.3 US: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.1.4 US: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.1.5 US: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.1.6 US: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.2.1 Overview

11.1.7.2.2 Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.2.3 Canada: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.2.4 Canada: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.2.5 Canada: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.2.6 Canada: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.7.3 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.3.1 Overview

11.1.7.3.2 Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.7.3.3 Mexico: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.7.3.4 Mexico: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.7.3.5 Mexico: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.7.3.6 Mexico: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.2 Europe: Branded Generics Market

11.2.1 Overview

11.2.2 Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.3 Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.4 Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.5 Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.6 Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

11.2.7.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.2 Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.3 Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.4 Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.1.5 Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.1 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.2 France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.3 France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.4 France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.2.5 France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.1 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.2 UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.3 UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.4 UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.3.5 UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.1 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.2 Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.3 Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.4 Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.4.5 Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.1 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.2 Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.3 Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.4 Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.5.5 Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.1 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.4 Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.2.7.6.5 Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.3 Asia Pacific Branded Generics Market Revenue and Forecasts To 2028

11.3.1 Overview

11.3.2 Asia Pacific Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.3 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.4 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.5 Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.6 Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7 Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.3.7.1 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.1.1 Overview

11.3.7.1.2 Japan: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.1.3 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.1.4 Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.1.5 Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.1.6 Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.2.1 Overview

11.3.7.2.2 China: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.2.3 China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.2.4 China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.2.5 China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.2.6 China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.3 India Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.3.1 Overview

11.3.7.3.2 India: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.3.3 India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.3.4 India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.3.5 India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.3.6 India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.4.1 Overview

11.3.7.4.2 South Korea: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.4.3 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.4.4 South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.4.5 South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.4.6 South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.5 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.5.1 Overview

11.3.7.5.2 Australia: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.3.7.5.3 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.5.4 Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.5.5 Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.5.6 Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.1 Overview

11.3.7.6.2 Rest of Asia Pacific: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.3 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.3.7.6.4 Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.3.7.6.5 Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.3.7.6.6 Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.4 Middle East & Africa: Branded Generics Market Revenue and Forecast To 2028

11.4.1 Overview

11.4.2 Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.3 Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.4 Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.5 Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.6 Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7 Middle East & Africa: Branded Generics Market, by Country, 2022 & 2028 (%)

11.4.7.1 UAE: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.1.1 Overview

11.4.7.1.2 UAE: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.1.3 UAE: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.1.4 UAE: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.1.5 UAE: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.1.6 UAE: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.2 Saudi Arabia: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.2.1 Overview

11.4.7.2.2 Saudi Arabia: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.2.3 Saudi Arabia: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.2.4 Saudi Arabia: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.2.5 Saudi Arabia: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.2.6 Saudi Arabia: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.3 South Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.3.1 Overview

11.4.7.3.2 South Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.3.3 South Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.3.4 South Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.3.5 South Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.3.6 South Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.4.7.4 Rest of Middle the East and Africa: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.4.7.4.1 Overview

11.4.7.4.2 Rest of Middle East & Africa: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.4.7.4.3 Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.4.7.4.4 Rest of Middle East & Africa: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.4.7.4.5 Rest of Middle East & Africa: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.4.7.4.6 Rest of Middle East & Africa: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.5 South and Central America Branded Generics Market Revenue and Forecast to 2028

11.5.1 Overview

11.5.2 South & Central America Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.3 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.4 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.5 South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.6 South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7 South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.5.7.1 Argentina Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.5.7.1.1 Overview

11.5.7.1.2 Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.1.3 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.1.4 Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.1.5 Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.1.6 Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2 Brazil: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2.1 Overview

11.5.7.2.2 Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.2.3 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.2.4 Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.2.5 Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.2.6 Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.5.7.3 Rest of South and Central America: Branded Generics Market– Revenue and Forecast to 2028 (USD Billion)

11.5.7.3.1 Overview

11.5.7.3.2 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.5.7.3.3 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.5.7.3.4 Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.5.7.3.5 Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.5.7.3.6 Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

12. Impact Of COVID-19 Pandemic on Branded Generics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.5 SAM: Impact Assessment of COVID-19 Pandemic

13. Branded Generics Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 MYLAN N.V.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GlaxoSmithKline plc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Bausch Health Companies Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Lupin

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 ASTRAZENECA PLC.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Dr. Reddy's Laboratories

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Par Pharmaceuticals, INC

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Sandoz International GMBH

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Aspen Holdings

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Hetero

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 2. North America Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 3. North America Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)

Table 4. North America Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 5. US Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 6. US Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 7. US Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8. US Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 9. Canada: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 10. Canada Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 11. Canada Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12. Canada Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 13. Mexico: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 14. Mexico Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 15. Mexico Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 16. Mexico Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 17. Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 18. Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 19. Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 20. Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 21. Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 22. Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 23. Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 24. Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 25. France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 26. France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 27. France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 28. France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 29. UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 30. UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 31. UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 32. UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 33. Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 34. Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 35. Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 36. Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 37. Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 38. Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 39. Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 40. Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 41. Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 42. Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 43. Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 44. Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 45. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).

Table 46. Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 47. Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 48. Asia Pacific: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 49. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 50. Japan: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 51. Japan: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 52. Japan: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 53. China: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 54. China: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 55. China: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 56. China: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 57. India: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 58. India: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 59. India: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 60. India: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 61. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 62. South Korea: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 63. South Korea: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 64. South Korea: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 65. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 66. Australia: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 67. Australia: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 68. Australia: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 69. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 70. Rest of Asia Pacific: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 71. Rest of Asia Pacific: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 72. Rest of Asia Pacific: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 73. Middle East & Africa Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 74. Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Billion)

Table 75. Middle East & Africa Branded Generics Market, by Drug Class– Revenue and Forecast to 2028 (US$ Billion)

Table 76. Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 77. UAE Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 78. UAE Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 79. UAE Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 80. UAE Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 81. Saudi Arabia: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 82. Saudi Arabia Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 83. Saudi Arabia Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 84. Saudi Arabia Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 85. South Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 86. South Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 87. South Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 88. South Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 89. Rest of Middle East & Africa: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 90. Rest of Middle East & Africa Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 91. Rest of Middle East & Africa Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 92. Rest of Middle East & Africa Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 93. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion).

Table 94. South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 95. South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 96. South & Central America: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 97. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 98. Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 99. Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 100. Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 101. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 102. Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 103. Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 104. Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 105. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 106. Rest of South & Central America: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 107. Rest of South & Central America: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 108. Rest of South & Central America: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 109. Organic Developments Done By Companies

Table 110. Inorganic Developments Done By Companies

Table 111. Glossary of Terms

The List of Companies - Branded Generics Market

1. MYLAN N.V.

2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

3. GlaxoSmithKline plc

4. Bausch Health (Valeant Pharmaceuticals)

5. Sandoz International Gmbh

6. Aspen Holdings

7. Par Pharmaceuticals

8. Lupin

9. Sanofi

10. AstraZeneca

11. Dr. Reddy's Laboratories Inc.

12. Hetero

Reason To Buy

• The key findings and recommendations highlight crucial progressive industry trends in the global Branded Generics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• A brief idea about the current competition in the Branded Generics Market.

• Provide strong and enough study of Branded Generics market that help in understanding the market.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Branded Generics market.

• Highlights key business priorities and focus in order to assist companies to realign their business strategies.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Branded Generics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry